Source:http://linkedlifedata.com/resource/pubmed/id/15608426
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2004-12-20
|
| pubmed:abstractText |
Apoptosis of circulating CD8+T cells seen in patients with squamous cell carcinoma of the head and neck (HNSCC) suggests a possibility of lymphocyte imbalance. Therefore, absolute numbers and percentages of T lymphocyte subsets were examined in the peripheral blood of patients with HNSCC and age-matched controls. Venous blood was obtained from 148 patients with HNSCC and 54 normal volunteers. Absolute numbers of CD3+, CD4+ and CD8+ T lymphocytes were determined using fluorobeads in a flow-cytometry-based technique. Percentages of T lymphocyte subsets were also evaluated by flow cytometry. The patients were grouped, at the time of blood draw (active vs. no evident disease, NED), type of therapy administered and the length of follow-up. Patients with HNSCC were found to have significantly lower absolute numbers of CD3+, CD4+and CD8+T cells than normal controls (NC). However, no differences in the percentages of T cell subsets between patients and NC were observed. Patients with active disease had significantly lower CD3+ and CD4+ T cell counts than those with NED. Patients with NED after surgery and radiotherapy had lower T cell counts than those treated by surgery alone. Patients who remained without evident disease for more than 2 years did not recover their T cell counts, and the T cell imbalance was evident many years after curative surgery. Patients with recurrent disease at the time of blood draw tended to have the lowest CD4+T cell counts. The TNM stage or site of the disease were not related to the absolute T cell count. Our data indicate that patients with HNSCC have altered lymphocyte homeostasis, which persists for months or years after curative therapies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0065-3071
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
62
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
161-72
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:15608426-Adult,
pubmed-meshheading:15608426-Aged,
pubmed-meshheading:15608426-Aged, 80 and over,
pubmed-meshheading:15608426-Apoptosis,
pubmed-meshheading:15608426-Biological Markers,
pubmed-meshheading:15608426-CD4 Lymphocyte Count,
pubmed-meshheading:15608426-CD4-CD8 Ratio,
pubmed-meshheading:15608426-Carcinoma, Squamous Cell,
pubmed-meshheading:15608426-Case-Control Studies,
pubmed-meshheading:15608426-Female,
pubmed-meshheading:15608426-Head and Neck Neoplasms,
pubmed-meshheading:15608426-Humans,
pubmed-meshheading:15608426-Lymphocyte Activation,
pubmed-meshheading:15608426-Lymphocyte Count,
pubmed-meshheading:15608426-Male,
pubmed-meshheading:15608426-Middle Aged,
pubmed-meshheading:15608426-Reference Values,
pubmed-meshheading:15608426-Sensitivity and Specificity,
pubmed-meshheading:15608426-Statistics, Nonparametric,
pubmed-meshheading:15608426-T-Lymphocyte Subsets
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
|
| pubmed:affiliation |
University of Pittsburgh Cancer Institute, Pittsburgh, PaA 15213, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|